SCHEMBL1008689

SCHEMBL1008689

CNC(=O)c1ccc(C)c(S(N)(=O)=O)c1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.41
PLK1 P53350 2/20 0.40
KMT2A Q03164 2/20 0.37
CA1 P00915 1/20 0.36
CA5A P35218 1/20 0.36
CA9 Q16790 1/20 0.36
JAK1 P23458 2/20 0.35
TYK2 P29597 2/20 0.35
ALDH1A1 P00352 4/20 0.34
HSD17B10 Q99714 3/20 0.34
KDM4E B2RXH2 3/20 0.34
HPGD P15428 2/20 0.34
MTNR1A P48039 1/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
USP2 O75604 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8568151 0.79 PLK1 (0.47) PLK1KMT2AJAK1TYK2ALDH1A1
SCHEMBL2652368 0.73 NPC1 (0.50) PLK1KMT2AJAK1TYK2ALDH1A1
SCHEMBL6269945 0.71 PLK1 (0.46) PLK1KMT2AALDH1A1HSD17B10HPGD
SCHEMBL8582664 0.71 KDM4E (0.41) CA2KMT2ACA1CA5ACA9
SCHEMBL8578770 0.70 CA2 (0.44) CA2CA1CA5ACA9ALDH1A1
SCHEMBL6392944 0.69 PLK1 (0.60) PLK1KMT2AALDH1A1HPGDMEN1
Hydrochloric Acid SCHEMBL27655722 0.68 PLK1 (0.58) PLK1KMT2AALDH1A1HPGDMEN1
SCHEMBL8582672 0.68 CA2 (0.45) CA2CA1CA5ACA9ALDH1A1
SCHEMBL8573287 0.67 PLK1 (0.57) PLK1KMT2AALDH1A1HSD17B10HPGD
SCHEMBL11445475 0.67 ALDH1A1 (0.49) PLK1JAK1TYK2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268612-A1 ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS Novartis AG (CH) 2011-01-05 EP disclosed
WO-2009118292-A1 ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS NOVARTIS AG (CH) 2009-10-01 WO disclosed